News Don't cut prices, cut taxes, pharma CEO tells Trump Industry plays key role in job creation too, says Novartis CEO.
News NICE recommends Novartis kidney cancer drug Afinitor finally recommended after rejection in 2011.
News Trump pledges 'bidding' to cut drug prices, stocks tumble Donald Trump’s first press conference of the year may have been farcical at times, as he fought off salacious allegations about his links with Russia, but the president-elect's attack on dr
News Trump 'already understands' need to incentivise R&D, says Me... Frazier takes swipe at price-hiking generics firms.
US Vericel hopes for US hit with Maci knee treatment Tissue engineering product previously flopped in EU.
News "I'm going to bring down drug prices" - Trump President-elect takes swipe at pharma after Time "Person of the Year" accolade.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.